CARDIOVASCULAR RISK AND ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS AND OBSERVATIONAL STUDIES (METADTCR)

被引:0
|
作者
Scailteux, L. -M. [1 ]
Naudet, F. [1 ]
Alimi, Q. [1 ]
Vincendeau, S. [1 ]
Oger, E. [1 ]
机构
[1] Rennes Univ Hosp, Rennes, France
关键词
D O I
10.1016/j.clinthera.2015.05.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:E3 / E3
页数:1
相关论文
共 50 条
  • [31] Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer A Systematic Review and Meta-analysis
    Magnan, Sindy
    Zarychanski, Ryan
    Pilote, Laurie
    Bernier, Laurence
    Shemilt, Michele
    Vigneault, Eric
    Fradet, Vincent
    Turgeon, Alexis F.
    JAMA ONCOLOGY, 2015, 1 (09) : 1261 - 1269
  • [32] Association of Androgen Deprivation Therapy in the Treatment of Prostate Cancer and Depression: A Systematic Review and Meta-analysis
    Nead, K. T.
    Yang, D. D.
    Sinha, S.
    Nguyen, P. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E257 - E257
  • [33] Intermittent Versus Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis
    Zheng, Yu-xiao
    Qin, Zhi-qiang
    Wang, Feng
    Zhang, Jian-zhong
    Cheng, Hong
    Si, Shu-hui
    Xu, Hao-xiang
    Wang, Yi
    Zhou, Xiang
    Li, Xiao
    Xue, Jian-xin
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2018, 6 (01): : 34 - 44
  • [34] Association of androgen deprivation therapy and depression in the treatment of prostate cancer: A systematic review and meta-analysis
    Nead, Kevin T.
    Sinha, Sumi
    Yang, David D.
    Nguyen, Paul L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (11) : 664.e1 - 664.e9
  • [35] Intermittent Versus Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis
    Magnan, S.
    Pilote, L.
    Bernier, L.
    Fradet, V.
    Vigneault, E.
    Turgeon, A. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S156 - S157
  • [36] Quantifying Observational Evidence for Risk of Fatal and Nonfatal Cardiovascular Disease Following Androgen Deprivation Therapy for Prostate Cancer: A Meta-analysis
    Bosco, Cecilia
    Bosnyak, Zsolt
    Malmberg, Anders
    Adolfsson, Jan
    Keating, Nancy L.
    Van Hemelrijck, Mieke
    EUROPEAN UROLOGY, 2015, 68 (03) : 386 - 396
  • [37] The prevalence of osteoporosis in men with prostate cancer on androgen deprivation therapy: a systematic review and meta-analysis
    Lassemillante, Annie-Claude
    Hooper, John
    Prins, John
    Doi, Suhail
    Wright, Olivia
    BJU INTERNATIONAL, 2013, 112 : 35 - 35
  • [38] Androgen Deprivation Therapy for Prostate Cancer Is Associated with Cardiovascular Morbidity and Mortality: A Meta-Analysis of Population-Based Observational Studies
    Zhao, Jinsheng
    Zhu, Shimiao
    Sun, Libin
    Meng, Fanzheng
    Zhao, Lin
    Zhao, Yusheng
    Tian, Hao
    Li, Ping
    Niu, Yuanjie
    PLOS ONE, 2014, 9 (09):
  • [39] Re: Association of Androgen Deprivation Therapy with Cardiovascular Death in Patients with Prostate Cancer: A Meta-Analysis of Randomized Trials
    See, William A.
    EUROPEAN UROLOGY, 2012, 61 (05) : 1066 - 1066
  • [40] Re: Association of Androgen Deprivation Therapy with Cardiovascular Death in Patients with Prostate Cancer: A Meta-Analysis of Randomized Trials
    Froehner, Michael
    Wirth, Manfred P.
    EUROPEAN UROLOGY, 2012, 62 (02) : 350 - 350